Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Center for International Blood and Marrow Transplant Research
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Center for International Blood and Marrow Transplant Research
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
City of Hope Medical Center
University of Illinois at Chicago
Memorial Sloan Kettering Cancer Center
Novartis
National Cancer Institute (NCI)
City of Hope Medical Center
City of Hope Medical Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Fred Hutchinson Cancer Center
City of Hope Medical Center
St. Jude Children's Research Hospital
Case Comprehensive Cancer Center
Institut Paoli-Calmettes
City of Hope Medical Center
City of Hope Medical Center
City of Hope Medical Center
Groupe Francophone des Myelodysplasies
University of Virginia
GCP-Service International West GmbH